Last reviewed · How we verify

thoracic epidural analgesia

Volgograd State Medical University · FDA-approved active Small molecule

Thoracic epidural analgesia delivers local anesthetic and/or opioid medications into the epidural space of the thoracic spine to block pain signals from the chest and upper abdomen.

Thoracic epidural analgesia delivers local anesthetic and/or opioid medications into the epidural space of the thoracic spine to block pain signals from the chest and upper abdomen. Used for Perioperative pain management in thoracic surgery, Perioperative pain management in upper abdominal surgery, Chronic pain conditions of the thorax and upper abdomen.

At a glance

Generic namethoracic epidural analgesia
Also known asThoracic Epidural Anesthesia, TEA, Thoracic Epidural
SponsorVolgograd State Medical University
ModalitySmall molecule
Therapeutic areaPain Management / Anesthesia
PhaseFDA-approved

Mechanism of action

This is a regional anesthesia technique rather than a systemically administered drug. Medications injected into the thoracic epidural space diffuse across the dura mater to block nerve roots and spinal cord segments, providing localized pain relief without the systemic effects of general anesthesia or high-dose systemic opioids. It is commonly used for perioperative pain management in thoracic and upper abdominal surgeries.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: